Skip to main content
. Author manuscript; available in PMC: 2013 Aug 16.
Published in final edited form as: Eur J Clin Invest. 2010 Aug 19;40(10):903–910. doi: 10.1111/j.1365-2362.2010.02347.x

Table 1.

Patient characteristics and biochemistry and laboratory variable

Control Pre-HD End-HD
Age 44.6 ± 4.7 43±5.9
Weight (kg) 78.3 ± 16.4 75.2±3.5
Lean body mass (kg) 42.4±2.4 40.0±2.8
Protein g• kg-1•day-1 1.37±0.05 1.45 ± 0.09
Calories kcal•kg-1•day-1 35.2±1.21 33.2±3.7
Hemoglobin (g/dL) 14.6±0.5a 12.1±0.3 12.3±0.5
BUN (mg/dL) 14.4±1.1 67.2±6.0b 18.1±3.7
Creatinine (mg/dL) 1.1±0.2 9.6±1.4b 4.8±0.7
Glucose (mg/dL) 84.6±9.6 89.8±10.1 105.2±9.7
Bicarbonate (meq/L) 23.2±0.5 23.6±0.8 27.3±2.4c
Albumin (g/dL) 4.2±0.2a 3.3±0.2 3.4±0.2
Insulin (μU/dL) 11.6±4.1 22.9±4.4d 17.5±4.2
Glucagon (pg/dL) 66.2±8.2 147.4±14.8e 90.2±8.5
IGF-1 (μg/L) 198.6±9.4 192.9±24.8
Cortisol (μg/dL) 14.4±3.1 10.3±1.2 17.7±2.4c
hsCRP (mg/dL) 1.01±0.19A 3.72±0.89 3.81±0.76
a

p<0.01 Control vs. Pre-HD and End-HD

b

p<0.001 Pre-HD vs. control and End-HD

c

p<0.01 End-HD vs. control

d

p<0.05 Pre-HD vs. Control

e

p<0.01 Pre-HD vs. Controls